Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Researchers have released Phase 3 clinical trial results for a novel multi-selective RAS(ON) inhibitor, demonstrating improved progression-free survival in patients with advanced pancreatic ductal adenocarcinoma. This targeted therapy specifically addresses ... Read More
Continuous Coverage
A rare Sumatran elephant calf was born in the Tesso Nilo National Park in Riau, Indonesia, marking a…
Public health officials are tracking respiratory viruses, gastrointestinal illnesses, and heat-related risks among the 4.4 million attendees and…
New Zealand Football Ferns defender CJ Bott has confirmed her marriage to partner Kelly Jurgens, sharing images of…
Australian Crawl, the iconic surf-rock band that defined the early 1980s Australian sound, is reuniting for the first…
The former president of the Trois-Rivières white-collar workers’ union faces criminal charges of fraud and breach of trust…
U.S.-Iran negotiations have triggered a fragile thaw in the Strait of Hormuz, with officials claiming it will remain…
Global Affairs
The intense thunderstorm that struck Pennsylvania this past weekend served as a dramatic backdrop to the group-stage match…
Markets And Money
The government of India has announced plans to recover the remains of “Green Boots,” a climber identified as…
Digital Culture
Microsoft has announced the closure of Compulsion Games, the developer behind South of Midnight, according to multiple reports.…
Science And Wellbeing
New research published this week in Nature overturns decades of public health advice, finding that even one standard…
Screen And Sound
Legendary Lithuanian band Lrytas splits after 33 years, sparking fan outrage as members pursue solo projects. The decision,…
Fixtures And Form
The Tunisian Football Federation dismissed head coach Jalel Kadri following a 5-1 defeat to Sweden in the 2026…
